Decibel Therapeutics downgraded to Neutral from Buy at H.C. Wainwright
PremiumThe FlyDecibel Therapeutics downgraded to Neutral from Buy at H.C. Wainwright
1y ago
Regeneron to acquire Decibel Therapeutics for $4.00 per share plus CVR
Premium
The Fly
Regeneron to acquire Decibel Therapeutics for $4.00 per share plus CVR
1y ago
Regeneron to acquire Decibel Therapeutics for $4.00 per share plus CVR
Premium
The Fly
Regeneron to acquire Decibel Therapeutics for $4.00 per share plus CVR
1y ago
Decibel Therapeutics to Present at the American Society of Gene and Cell Therapy (ASGCT) 26th Annual Meeting
PremiumPress ReleasesDecibel Therapeutics to Present at the American Society of Gene and Cell Therapy (ASGCT) 26th Annual Meeting
1y ago
Decibel Therapeutics receives European ODD for DB-OTO
Premium
The Fly
Decibel Therapeutics receives European ODD for DB-OTO
1y ago
Decibel Therapeutics Receives European Orphan Drug Designation for Lead Gene Therapy Candidate DB-OTO
Premium
Press Releases
Decibel Therapeutics Receives European Orphan Drug Designation for Lead Gene Therapy Candidate DB-OTO
1y ago
Decibel downgraded to Market Perform from Outperform at SVB Securities
PremiumThe FlyDecibel downgraded to Market Perform from Outperform at SVB Securities
2y ago
Decibel downgraded to Market Perform from Outperform at SVB Securities
Premium
The Fly
Decibel downgraded to Market Perform from Outperform at SVB Securities
2y ago
Decibel Therapeutics reports Q4 cash position $104.6M vs $162.3M last year
Premium
The Fly
Decibel Therapeutics reports Q4 cash position $104.6M vs $162.3M last year
2y ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100